Alpha Cognition (ACOG)
9.10
+0.12 (1.34%)
Upcoming Events
Latest Headlines
Alpha Cognition to Present New ZUNVEYL® (Benzgalantamine) Clinical and Real-World Data at ASCP Annual Meeting and NEI Fall Congress
October 6, 2026 8:30 AM - BizWire
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2026 7:06 PM - BizWire
Form 4 Alpha Cognition Inc. For: Oct 01 Filed by: Opaleye Management Inc.
October 2, 2026 4:06 PM - SEC Filing
Alpha Cognition Announces CONVERGE Real-World Evidence on ZUNVEYL®(Benzgalantamine) Use in Long-Term Care
October 1, 2026 8:30 AM - BizWire
Form 4 Alpha Cognition Inc. For: Sep 24 Filed by: Opaleye Management Inc.
September 28, 2026 7:58 PM - SEC Filing
Form SCHEDULE 13G Alpha Cognition Inc. Filed by: MANCHESTER MANAGEMENT CO LLC
September 23, 2026 6:13 PM - SEC Filing
Form 4 Alpha Cognition Inc. For: Sep 14 Filed by: Opaleye Management Inc.
September 16, 2026 5:58 PM - SEC Filing
Form 4 Alpha Cognition Inc. For: Aug 21 Filed by: Wills Robert James
August 24, 2026 2:53 PM - SEC Filing
B.Riley Starts Alpha Cognition Inc (ACOG) at Buy
August 20, 2026 2:44 AM - StreetInsider
Alpha Cognition Inc (ACOG) PT Raised to $20 at H.C. Wainwright
August 18, 2026 6:40 AM - StreetInsider
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) 2Q26
August 17, 2026 10:44 AM - StreetInsider
Form 10-Q Alpha Cognition Inc. For: Jun 30
August 13, 2026 4:48 PM - SEC Filing
Alpha Cognition reports Q2 2026 revenue of $6M as net loss narrows
August 13, 2026 4:06 PM - StreetInsider
Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update
August 13, 2026 4:05 PM - BizWire
Form 4 Alpha Cognition Inc. For: Jul 31 Filed by: Opaleye Management Inc.
August 4, 2026 4:50 PM - SEC Filing
Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update
August 3, 2026 8:30 AM - BizWire
Alpha Cognition receives European patent for Alzheimer's drug Zunveyl
July 29, 2026 8:30 AM - StreetInsider
Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease
July 29, 2026 8:30 AM - BizWire
Form 4 Alpha Cognition Inc. For: Jul 24 Filed by: Opaleye Management Inc.
July 28, 2026 4:05 PM - SEC Filing
Form SCHEDULE 13G/A Alpha Cognition Inc. Filed by: Opaleye Management Inc.
July 24, 2026 4:05 PM - SEC Filing
Form 4 Alpha Cognition Inc. For: Jul 22 Filed by: Opaleye Management Inc.
July 24, 2026 4:05 PM - SEC Filing
Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit
July 10, 2026 8:30 AM - BizWire
Raymond James Starts Alpha Cognition Inc (ACOG) at Outperform
July 10, 2026 6:05 AM - StreetInsider
Full Article List
